GLOBUS MEDICAL, INC. Investment Income, Amortization of Premium
GLOBUS MEDICAL, INC. (GMED) reported Investment Income, Amortization of Premium of $1.68 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeAmortizationOfPremium · last filed 2019-02-21
- GLOBUS MEDICAL, INC. investment income, amortization of premium for the quarter ending 2018-12-31 was -$131.00K, a 131.72% decline year-over-year.
- GLOBUS MEDICAL, INC. investment income, amortization of premium for the quarter ending 2018-09-30 was $331.00K, a 17.87% decline year-over-year.
- GLOBUS MEDICAL, INC. investment income, amortization of premium for the quarter ending 2018-06-30 was $692.00K, a 18.30% decline year-over-year.
- GLOBUS MEDICAL, INC. investment income, amortization of premium for the quarter ending 2018-03-31 was $785.00K, a 22.12% decline year-over-year.
- GLOBUS MEDICAL, INC. investment income, amortization of premium for fiscal 2018 was $1.68M, a 37.21% decline from fiscal 2017.
- GLOBUS MEDICAL, INC. investment income, amortization of premium for fiscal 2017 was $2.67M, a 34.34% decline from fiscal 2016.
- GLOBUS MEDICAL, INC. investment income, amortization of premium for fiscal 2016 was $4.07M, a 21.29% increase from fiscal 2015.
- GLOBUS MEDICAL, INC. investment income, amortization of premium for fiscal 2015 was $3.35M, a 25.15% increase from fiscal 2014.
| Period end | Investment Income, Amortization of Premium 3 month | Investment Income, Amortization of Premium 6 month | Investment Income, Amortization of Premium 9 month | Investment Income, Amortization of Premium 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $200.00K derived: sum of 2 quarters · filed 2019-02-21 | $892.00K derived: sum of 3 quarters · filed 2019-02-21 | $1.68M 10-K · filed 2019-02-21 |
| 2018-09-30 | $331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.02M derived: sum of 2 quarters · filed 2018-11-08 | $1.81M 10-Q · filed 2018-11-08 | $2.22M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | $692.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.48M 10-Q · filed 2018-08-02 | $1.89M derived: sum of 3 quarters · filed 2019-02-21 | $2.29M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | $785.00K 10-Q · filed 2018-05-03 | $1.20M derived: sum of 2 quarters · filed 2019-02-21 | $1.60M derived: sum of 3 quarters · filed 2019-02-21 | $2.45M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $816.00K derived: sum of 2 quarters · filed 2019-02-21 | $1.66M derived: sum of 3 quarters · filed 2019-02-21 | $2.67M 10-K · filed 2019-02-21 |
| 2017-09-30 | $403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.25M derived: sum of 2 quarters · filed 2018-11-08 | $2.26M 10-Q · filed 2018-11-08 | $3.26M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.85M 10-Q · filed 2018-08-02 | $2.86M derived: sum of 3 quarters · filed 2019-02-21 | $3.84M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $1.01M 10-Q · filed 2018-05-03 | $2.01M derived: sum of 2 quarters · filed 2019-02-21 | $2.99M derived: sum of 3 quarters · filed 2019-02-21 | $4.12M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $1.98M derived: sum of 2 quarters · filed 2019-02-21 | $3.12M derived: sum of 3 quarters · filed 2019-02-21 | $4.07M 10-K · filed 2019-02-21 |
| 2016-09-30 | $982.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.11M derived: sum of 2 quarters · filed 2017-11-09 | $3.07M 10-Q · filed 2017-11-09 | $4.07M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.08M 10-Q · filed 2017-08-03 | $3.09M derived: sum of 3 quarters · filed 2018-02-22 | $4.07M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $953.00K 10-Q · filed 2017-05-04 | $1.96M derived: sum of 2 quarters · filed 2018-02-22 | $2.94M derived: sum of 3 quarters · filed 2018-02-22 | $3.67M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.98M derived: sum of 2 quarters · filed 2018-02-22 | $2.71M derived: sum of 3 quarters · filed 2018-02-22 | $3.35M 10-K · filed 2018-02-22 |
| 2015-09-30 | $982.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.71M derived: sum of 2 quarters · filed 2016-11-09 | $2.35M 10-Q · filed 2016-11-09 | $2.96M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $730.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $1.37M 10-Q · filed 2016-07-27 | $1.98M derived: sum of 3 quarters · filed 2017-03-16 | $2.48M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $640.00K 10-Q · filed 2016-05-04 | $1.25M derived: sum of 2 quarters · filed 2017-03-16 | $1.75M derived: sum of 3 quarters · filed 2017-03-16 | $2.52M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $607.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.11M derived: sum of 2 quarters · filed 2017-03-16 | $1.88M derived: sum of 3 quarters · filed 2017-03-16 | $2.68M 10-K · filed 2017-03-16 |
| 2014-09-30 | $507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.27M derived: sum of 2 quarters · filed 2015-11-04 | $2.07M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $765.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $1.57M 10-Q · filed 2015-07-31 | ||
| 2014-03-31 | $801.00K 10-Q · filed 2015-05-05 | |||
| 2013-12-31 | $2.36M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |